Literature DB >> 15808171

Triamcinolone acetonide concentration after filtration of the solvent agent.

Ulrich H M Spandau1, Mathias Derse, Paul Schmitz-Valckenberg, Christos Papoulis, Bernd-Udo Sagstetter, Karlheinz Stiefvater, Jost B Jonas.   

Abstract

PURPOSE: To determine the amount of triamcinolone acetonide and the preservative benzyl alcohol after filtration.
DESIGN: Laboratory investigation.
METHODS: The probes were prepared by two different hospital pharmacies. The probes of the first pharmacy included 20 probes with 25-mg triamcinolone acetonide, unfiltered (n = 5 probes) or filtered (n = 5), or with 4-mg triamcinolone acetonide, filtered (n = 5) or unfiltered (n = 5). The probes for the second pharmacy were filtered (n = 3) probes of 25-mg triamcinolone acetonide.
RESULTS: For the probes of the first pharmacy, triamcinolone acetonide dosages were 2.4 +/- 0.8 mg, 3.1 +/- 0.6 mg, 12.8 +/- 0.7 mg, and 23.4 +/- 2.3 mg, respectively, for the filtered 4-mg probes, unfiltered 4-mg probes, filtered 25-mg probes, and unfiltered 25-mg probes, respectively. For the second pharmacy, mean triamcinolone acetonide dosage was 23.8 +/- 0.6 mg for the 25-mg filtered probes and contained benzyl alcohol in a mean concentration of 0.0013 +/- 0.0001 mg/0.1 ml.
CONCLUSIONS: Depending on the method employed and the pharmacy, preparation of triamcinolone acetonide including filtration of the solvent agent leads to a marked inter-pharmacy variation and a relatively low intra-pharmacy variation in the reduction of triamcinolone acetonide dosage.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15808171     DOI: 10.1016/j.ajo.2004.09.059

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  2 in total

1.  Vehicle of triamcinolone acetonide is associated with retinal toxicity and transient increase of lens density.

Authors:  Wang Kai; Jiang Yanrong; Li Xiaoxin
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2006-02-02       Impact factor: 3.117

2.  Retinal angiomatous proliferation treated by intravitreal triamcinolone and photodynamic therapy with verteporfin.

Authors:  Massimo Nicolò; Davidina Ghiglione; Silvio Lai; Giovanni Calabria
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2006-03-08       Impact factor: 3.117

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.